EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population

Aaron M Carlson iD, Carlos E V Sollero, Andrew B Wolf, Stefan Sillau, Barrie L Schmitt, Kelli M Money iD, Kavita V Nair, Amanda L Piquet, Jeffrey L Bennett iD

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.52268 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Aaron M Carlson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Neuromyelitis Optica, Aquaporin 4. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Horizon Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To define the epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder (NMOSD) in a large US health system.

Methods

We completed a retrospective observational study of adult patients in the University of Colorado Health System from 1 January 2011 to 31 December 2020, using Health Data Compass (HDC), a data warehouse that combines electronic health information with claims and public health data in Colorado. We screened HDC for patients with either (1) an abnormal aquaporin‐4 IgG test or (2) any G36 ICD‐10 code. We extracted key clinical elements by chart review and confirmed diagnosis by the 2015 International Panel for NMO Diagnosis criteria. Annual incidence and prevalence rates were calculated.

Results

Our population consisted of 2,475,591 individuals contributing 11,103,522.72 person‐years of observation. In total, 115 seropositive NMOSD patients were identified. The average yearly incidence was 0.22 per 100,000 person‐years. Age and sex‐adjusted prevalence (per 100,000) was 4.33, and highest among those identifying as Asian or Pacific Islander (17.72), and Black (14.74), as separately by Hispanic ethnicity (8.02). Prevalence was higher in women (6.20:1 female:male ratio). Transverse myelitis (45%) and optic neuritis (43%) were the most common presenting clinical syndromes. In total, 6% of initial presentations were characterized by short‐segment transverse myelitis without other features.

Interpretation

Seropositive NMOSD incidence is higher in our cohort than many contemporary studies. Women and those identifying as Asian or Pacific Islander, Black, and Hispanic shoulder the highest burden of disease. Clinical onset with short‐segment myelitis underscores the need for serum aquaporin‐4 IgG testing in acute myelitis presentations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuromyelitis OpticaAquaporin 4HumansFemaleMaleAdultMiddle AgedRetrospective StudiesIncidenceAgedPrevalenceYoung AdultUnited StatesAdolescent

Substanzen

Aquaporin 4AQP4 protein, human

Autor:innen und Institutionen

  • Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Department of Neurology, University of Rochester, Rochester, New York, USA.
  • University of Colorado Health Memorial Hospital, Colorado Springs, Colorado, USA.
  • Department of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
  • Departments of Neurology and Ophthalmology, Programs in Neuroscience and Immunology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, Colorado, USA.

ORCID-Profile: Aaron M Carlson, Kelli M Money, Jeffrey L Bennett

Förderung

  • Horizon Therapeutics

Zitieren

APA

Carlson, A. M., Sollero, C. E. V., Wolf, A. B., Sillau, S., Schmitt, B. L., Money, K. M., Nair, K. V., Piquet, A. L., & Bennett, J. L. (2025). The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52268

Vancouver

Carlson AM, Sollero CEV, Wolf AB, Sillau S, Schmitt BL, Money KM, et al. The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.52268

BibTeX
@article{Carlson2025,
  author = {Carlson, Aaron M and Sollero, Carlos E V and Wolf, Andrew B and Sillau, Stefan and Schmitt, Barrie L and Money, Kelli M and Nair, Kavita V and Piquet, Amanda L and Bennett, Jeffrey L},
  title = {The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.52268}
}
Kostenlos starten →